DK172329B1 - Polydisperse, native Pseudomonas-flagella(H)-antigener (FAg) i polymer form og fremgangsmåde til deres udvinding - Google Patents

Polydisperse, native Pseudomonas-flagella(H)-antigener (FAg) i polymer form og fremgangsmåde til deres udvinding Download PDF

Info

Publication number
DK172329B1
DK172329B1 DK421486A DK421486A DK172329B1 DK 172329 B1 DK172329 B1 DK 172329B1 DK 421486 A DK421486 A DK 421486A DK 421486 A DK421486 A DK 421486A DK 172329 B1 DK172329 B1 DK 172329B1
Authority
DK
Denmark
Prior art keywords
antigens
flagella
alanine
antigen
threonine
Prior art date
Application number
DK421486A
Other languages
Danish (da)
English (en)
Other versions
DK421486A (da
DK421486D0 (da
Inventor
Thomas C Montie
Friedrich Dorner
James L Mcdonel
Artur Mitterer
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of DK421486A publication Critical patent/DK421486A/da
Publication of DK421486D0 publication Critical patent/DK421486D0/da
Application granted granted Critical
Publication of DK172329B1 publication Critical patent/DK172329B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK421486A 1985-01-14 1986-09-03 Polydisperse, native Pseudomonas-flagella(H)-antigener (FAg) i polymer form og fremgangsmåde til deres udvinding DK172329B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AT0007285A AT384032B (de) 1985-01-14 1985-01-14 Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
AT7285 1985-01-14
PCT/AT1986/000002 WO1986003974A1 (en) 1985-01-14 1986-01-13 POLYDISPERSED NATIVE PSEUDOMONAS-FLAGELLA (H)-ANTIGENS (FAg) AND METHODS FOR THEIR PREPARATION
AT8600002 1986-01-13

Publications (3)

Publication Number Publication Date
DK421486A DK421486A (da) 1986-09-03
DK421486D0 DK421486D0 (da) 1986-09-03
DK172329B1 true DK172329B1 (da) 1998-03-23

Family

ID=3480790

Family Applications (1)

Application Number Title Priority Date Filing Date
DK421486A DK172329B1 (da) 1985-01-14 1986-09-03 Polydisperse, native Pseudomonas-flagella(H)-antigener (FAg) i polymer form og fremgangsmåde til deres udvinding

Country Status (10)

Country Link
US (1) US4831121A (es)
EP (1) EP0208743B1 (es)
JP (1) JPH085801B2 (es)
AT (2) AT384032B (es)
CA (1) CA1263307C (es)
DE (1) DE3686961D1 (es)
DK (1) DK172329B1 (es)
ES (1) ES8800275A1 (es)
FI (1) FI85221C (es)
WO (1) WO1986003974A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5237053A (en) * 1986-06-24 1993-08-17 Immuno Aktiengesellschaft Preparation active against Pseudomonas aeruginosa infections and methods of producing them
AT391080B (de) * 1986-06-24 1990-08-10 Immuno Ag Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
AT390192B (de) * 1988-08-29 1990-03-26 Immuno Ag Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
US4994161A (en) * 1989-02-02 1991-02-19 University Of New Hampshire Apparatus and method for macromolecular charge determination
WO2005091716A2 (en) * 2004-03-26 2005-10-06 Quark Biotech, Inc. Annexin ii and uses thereof
US8263078B2 (en) 2007-09-05 2012-09-11 Inotek Pharmaceuticals Corporation Antibodies against flagellin and uses thereof
US20100239583A1 (en) * 2009-03-04 2010-09-23 Inotek Pharmaceuticals Corporation Antibodies against flagellin and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928565A (en) * 1971-10-19 1975-12-23 Yuzuru Homma Pharmaceutical preparation of pseudomonas aeruginosa bacterial component possessing anti-tumor and anti-infection properties
JPS51133489A (en) * 1975-05-14 1976-11-19 Tokyo Daigaku Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities
FR2460139A1 (fr) * 1979-06-29 1981-01-23 Pasteur Institut Fraction antigenique glycopeptidique vaccinante a tres grande immunogenicite isolee de cultures de germes pathogenes, procedes d'isolement de cette fraction et vaccins contenant ladite fraction
US4271147A (en) * 1980-01-10 1981-06-02 Behringwerke Aktiengesellschaft Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
EP0048422A3 (en) * 1980-09-15 1983-08-24 Bactex Incorporated Pili of pseudomonas aeruginosa and utilization of same as vaccines against infectionary p.aeruginosa
US4470924A (en) * 1981-12-30 1984-09-11 Iglewski Barbara M Nontoxic, immunologically crossreactive toxin A protein from Pseudomonas aeruginosa
US4578458A (en) * 1983-03-23 1986-03-25 Brigham And Women's Hospital Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa

Also Published As

Publication number Publication date
ES8800275A1 (es) 1987-11-01
AT384032B (de) 1987-09-25
JPS62501363A (ja) 1987-06-04
ATE81471T1 (de) 1992-10-15
US4831121A (en) 1989-05-16
JPH085801B2 (ja) 1996-01-24
DE3686961D1 (de) 1992-11-19
FI863677A0 (fi) 1986-09-11
CA1263307A (en) 1989-11-28
ES550831A0 (es) 1987-11-01
EP0208743A1 (de) 1987-01-21
CA1263307C (en) 1989-11-28
EP0208743B1 (de) 1992-10-14
DK421486A (da) 1986-09-03
FI863677A (fi) 1986-09-11
ATA7285A (de) 1987-02-15
FI85221C (fi) 1992-03-25
WO1986003974A1 (en) 1986-07-17
FI85221B (fi) 1991-12-13
DK421486D0 (da) 1986-09-03

Similar Documents

Publication Publication Date Title
Nagai et al. Specific skin-reactive protein from culture filtrate of Mycobacterium bovis BCG
Finkelstein et al. Purification and characterization of the soluble hemagglutinin (cholera lectin)(produced by Vibrio cholerae
Irons et al. Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography
Kobayashi et al. Purification and chemical properties of flagellin
US4681761A (en) Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
DK165358C (da) Renset Bordetella pertussis antigen, vaccine indeholdende et sådant antigen og fremgangsmåde til isolering af et sådant ant
CN1067679A (zh) 重组dna衍生的霍乱毒素亚基类似物
CS244906B2 (en) Production method of antigen agent for limitation or prevention of tooth defects
Martinez et al. A single amino acid substitution responsible for altered flagellar morphology
CN87104828A (zh) 用作疫苗和诊断标记的淋病奈瑟氏菌植物凝血素及其制备方法
DK172329B1 (da) Polydisperse, native Pseudomonas-flagella(H)-antigener (FAg) i polymer form og fremgangsmåde til deres udvinding
Quinn et al. Carbohydrate-reactive, pore-forming outer membrane proteins of Aeromonas hydrophila
Lytton et al. Isolation and partial characterization of the reduction-modifiable protein of Neisseria gonorrhoeae.
Everett et al. Characterization of lipoprotein EnvA in Chlamydia psittaci 6BC
Rubin et al. Specific heterologous enhancement of immune responses: V. Isolation of a soluble enhancing factor from supernatants of specifically stimulated and allogeneically induced lymphoid cells
Sachdev et al. Isolation and characterization of glycoproteins from canine tracheal mucus
EP0298991B1 (en) Novel lectins derived from bacterial pili
Lens et al. Sex-specific glycoproteins in Chlamydomonas flagella an immunological study
Goel New method for the isolation of membranes from Mycoplasma gallisepticum
JPH10506521A (ja) ヘリコバクターピロリニッケル結合タンパク質
Ferrone et al. A biologic and chemical profile of histocompatibility antigens
Sheladia et al. Isolation, purification, and partial characterization of type VA hemagglutinin from Escherichia coli GV-12, O1: H
Adachi et al. Possible role of protein (s) as antigenic determinant of the type-specific main antigen of Leptospira kremastos strain Kyoto
Young et al. Reassembly of a fimbrial hemagglutinin from Pseudomonas solanacearum after purification of the subunit by preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis
DE19728834C2 (de) Eisenreduktase

Legal Events

Date Code Title Description
ATS Application withdrawn
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK